CLI24-001: First-in-human Study of SEL24/MEN1703, an Oral Dual PIM/FLT3 Kinase Inhibitor, in Patients with Acute Myeloid Leukemia.
Journal of Clinical Oncology(2019)
Key words
Pim Oncogenes
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined